{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/CRDF",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Cardiff Oncology, Inc. (NASDAQ: CRDF) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Cardiff Oncology, Inc., listed on NASDAQ under ticker CRDF, with ISIN US14147L1089 and LEI 549300AHOLZBHHYFWP04. Its security type is Corporate. Segment is not on the record. Sector is 2836 Biological Products, (No Diagnostic Substances). Jurisdiction is United States, Delaware. Status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 48 filings in the twelve months to 2026-11-08, across 27 filing days. The median gap between filing days is 7.0 days. The latest filing is dated 2026-10-27, 12 days before the record date, and is of type directors_dealings. The NASDAQ median cadence gap is 6.0 days, with a median of 52 filings and a median latency of 5.0 days across 4,359 issuers. The sector median cadence gap is 5.5 days, with a median of 65.5 filings and a median latency of 4.0 days across 176 issuers.\n\n## Auditor\n\nThe auditor of record is BDO USA, P.C., located in San Diego, California. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change lines. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. Halt flag: listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the investor-relations pages read for this issuer.\n\n## Open research\n\nThe record holds 2 openly published research notes, both by Noble Capital Markets: dated 2026-01-05 and 2026-02-26.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n11 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)\n- https://data.sec.gov/submissions/CIK0001213037.json (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/CRDF (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://www.sec.gov/Archives/edgar/data/1213037/000119312526067464/crdf-20251231.htm (the auditor)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://dashboard.channelchek.com/wp-content/uploads/pdf/CRDF_20260226_28079.pdf (open research)\n- https://dashboard.channelchek.com/wp-content/uploads/pdf/CRDF_20260105_27958.pdf (open research)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/CRDF (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1213037/000119312526067464/crdf-20251231.htm",
    "state": "sourced",
    "value": "BDO USA, P.C."
   },
   "auditor_firm_id": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1213037/000119312526067464/crdf-20251231.htm",
    "state": "sourced",
    "value": "243"
   },
   "auditor_location": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1213037/000119312526067464/crdf-20251231.htm",
    "state": "sourced",
    "value": "San Diego, California"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/CRDF",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 176,
     "median_cadence_gap_days": 5.5,
     "median_filings": 65.5,
     "median_latency_days": 4,
     "name": "2836 Biological Products, (No Diagnostic Substances)"
    }
   },
   "by_type": {
    "agm_egm": 7,
    "corporate_news": 7,
    "director_change": 3,
    "directors_dealings": 20,
    "prospectus": 1,
    "regulatory_filing": 4,
    "results": 5,
    "takeover": 1
   },
   "cadence_median_gap_days": 7,
   "filing_days": 27,
   "filings": 48,
   "latency_days": 12,
   "latest": [
    {
     "category": "3",
     "date": "2026-10-27",
     "source": "https://www.sec.gov/Archives/edgar/data/1213037/000149315226048722/xslF345X06/ownership.xml",
     "title": "3 — 3",
     "type": "directors_dealings"
    },
    {
     "category": "8-K",
     "date": "2026-10-27",
     "source": "https://www.sec.gov/Archives/edgar/data/1213037/000149315226048720/form8-k.htm",
     "title": "8-K — 8-K (items 5.02,5.03,7.01,9.01)",
     "type": "director_change"
    },
    {
     "category": "8-K",
     "date": "2026-10-22",
     "source": "https://www.sec.gov/Archives/edgar/data/1213037/000149315226048111/form8-k.htm",
     "title": "8-K — 8-K (items 5.07)",
     "type": "agm_egm"
    },
    {
     "category": "8-K",
     "date": "2026-09-14",
     "source": "https://www.sec.gov/Archives/edgar/data/1213037/000149315226042506/form8-k.htm",
     "title": "8-K — 8-K (items 1.01,7.01,9.01)",
     "type": "corporate_news"
    },
    {
     "category": "DEFA14A",
     "date": "2026-08-26",
     "source": "https://www.sec.gov/Archives/edgar/data/1213037/000119312526368287/crdf_defa14a_special_202.htm",
     "title": "DEFA14A — DEFA14A",
     "type": "agm_egm"
    }
   ],
   "latest_filing_date": "2026-10-27",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/CRDF",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (ISINs mapped to the LEI)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest",
    "state": "sourced",
    "value": "US14147L1089"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001213037.json",
    "state": "sourced",
    "value": "United States — Delaware"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN US14147L1089)",
    "state": "sourced",
    "value": "549300AHOLZBHHYFWP04"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001213037.json",
    "state": "sourced",
    "value": "Cardiff Oncology, Inc."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001213037.json",
    "state": "sourced",
    "value": "2836 Biological Products, (No Diagnostic Substances)"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001213037.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "CRDF"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:4cbb59c0f8ef59628010627b7a944ba4486c7024e1e6ad5c4b64480de648e1b3",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [
    {
     "date": "2026-02-26",
     "kind": "independent",
     "publisher": "Noble Capital Markets",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-11",
     "source": "https://dashboard.channelchek.com/wp-content/uploads/pdf/CRDF_20260226_28079.pdf",
     "state": "sourced",
     "title": "Cardiff Oncology FY2025 Reported With Onvansertib Phase 2b Data Review"
    },
    {
     "date": "2026-01-05",
     "kind": "independent",
     "publisher": "Noble Capital Markets",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-11",
     "source": "https://dashboard.channelchek.com/wp-content/uploads/pdf/CRDF_20260105_27958.pdf",
     "state": "sourced",
     "title": "Initiating Coverage With A $12 Price Target"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/CRDF",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:4cbb59c0f8ef59628010627b7a944ba4486c7024e1e6ad5c4b64480de648e1b3",
 "path": "/us/NASDAQ/CRDF",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Cardiff Oncology, Inc., listed on NASDAQ under ticker CRDF, with ISIN US14147L1089 and LEI 549300AHOLZBHHYFWP04. Its security type is Corporate. Segment is not on the record. Sector is 2836 Biological Products, (No Diagnostic Substances). Jurisdiction is United States, Delaware. Status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 48 filings in the twelve months to 2026-11-08, across 27 filing days. The median gap between filing days is 7.0 days. The latest filing is dated 2026-10-27, 12 days before the record date, and is of type directors_dealings. The NASDAQ median cadence gap is 6.0 days, with a median of 52 filings and a median latency of 5.0 days across 4,359 issuers. The sector median cadence gap is 5.5 days, with a median of 65.5 filings and a median latency of 4.0 days across 176 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is BDO USA, P.C., located in San Diego, California. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change lines. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. Halt flag: listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the investor-relations pages read for this issuer.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds 2 openly published research notes, both by Noble Capital Markets: dated 2026-01-05 and 2026-02-26.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "11 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001213037.json"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/CRDF"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the auditor",
   "source": "https://www.sec.gov/Archives/edgar/data/1213037/000119312526067464/crdf-20251231.htm"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "open research",
   "source": "https://dashboard.channelchek.com/wp-content/uploads/pdf/CRDF_20260226_28079.pdf"
  },
  {
   "for": "open research",
   "source": "https://dashboard.channelchek.com/wp-content/uploads/pdf/CRDF_20260105_27958.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/CRDF"
  }
 ],
 "title": "Cardiff Oncology, Inc. (CRDF) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}